Company / Capital Expenditures
Apogee Therapeutics, Inc. Capital Expenditures History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.2M
FY2024
5-year range
$167.0K / $1.2M
FY2023-FY2024
Trend
+589.8%
vs FY2023
Sector context
#109 of 194
Health Care
What the data says
At $1M, Apogee Therapeutics, Inc.'s capital expenditures ranks #109 of 194 in the Health Care sector.
Based on SEC 10-K filings.
$1M in FY2024.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 194 in Health CareTop 56% of 194This company $1.2M Sector average $117.5M
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2024, capital expenditures increased 589.8% year-over-year.
- Ranks #109 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.2M | +589.8% |
| FY2023 | $167.0K | - |
| FY2022 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026